influenza
viru
affect
respiratori
tract
direct
viral
infect
damag
immun
system
respons
human
respiratori
epithelium
site
hemagglutinin
ha
molecul
effect
cleav
gener
infecti
viru
particl
viru
transmiss
occur
suscept
individu
contact
aerosol
respiratori
fomit
infect
individu
inabl
lung
perform
primari
function
ga
exchang
result
multipl
mechan
includ
obstruct
airway
loss
alveolar
structur
loss
lung
epitheli
integr
direct
epitheli
cell
kill
degrad
critic
extracellular
matrix
approxim
hospit
patient
laboratoryconfirm
influenza
diagnos
acut
pneumonia
patient
develop
pneumonia
like
year
old
year
old
caucasian
nurs
home
resid
chronic
lung
heart
diseas
histori
smoke
immunocompromis
influenza
primarili
caus
sever
pneumonia
also
present
conjunct
follow
secondari
bacteri
infect
commonli
staphylococcu
aureu
streptococcu
pneumonia
influenza
associ
high
predisposit
bacteri
sepsi
ard
viral
infect
present
concurr
bacteri
pneumonia
known
occur
frequenc
adult
pediatr
popul
subtyp
associ
unpreced
high
level
intens
care
unit
icu
admiss
influenza
predomin
viral
etiolog
acut
respiratori
distress
syndrom
ard
adult
risk
factor
independ
associ
ard
age
year
old
pregnanc
obes
protect
factor
femal
sex
influenza
vaccin
infect
influenza
influenza
b
virus
icu
particularli
winter
season
influenza
suspect
patient
typic
symptom
epidemiolog
also
patient
sever
pneumonia
ard
sepsi
without
bacteri
coinfect
well
patient
enceph
myocard
rhabdomyolysi
human
influenza
viru
infect
replic
primarili
respiratori
epithelium
cell
type
includ
mani
immun
cell
infect
viru
initi
viral
protein
product
howev
viral
replic
effici
vari
among
cell
type
human
respiratori
epithelium
site
hemagglutinin
ha
molecul
effect
cleav
gener
infecti
viru
particl
viru
transmiss
occur
suscept
individu
come
contact
aerosol
respiratori
fomit
infect
individu
ferret
tradit
use
model
influenza
transmiss
human
influenza
virus
need
adapt
infect
transmit
among
ferret
studi
ferret
identifi
soft
palat
major
sourc
influenza
virus
transmit
individu
notabl
soft
palat
enrich
sialic
acid
prefer
hemagglutinin
protein
current
found
circul
human
influenza
virus
enrich
also
occur
soft
palat
human
primari
mechan
influenza
pathophysiolog
result
lung
inflamm
compromis
caus
direct
viral
infect
respiratori
epithelium
combin
effect
lung
inflamm
caus
immun
respons
recruit
handl
spread
viru
tabl
inflamm
spread
system
manifest
multiorgan
failur
consequ
gener
downstream
lung
compromis
sever
respiratori
distress
associ
also
observ
influenza
viru
infect
cardiac
sequela
includ
increas
risk
myocardi
diseas
week
follow
influenza
viru
infect
mechan
beyond
gener
inflammatori
profil
still
unresolv
influenza
viru
infect
respiratori
epitheli
cell
line
upper
includ
nasal
lower
alveoli
respiratori
tract
key
paramet
determin
extent
associ
diseas
degre
lower
respiratori
tract
becom
invad
viru
infect
alveolar
epitheli
cell
particular
appear
drive
develop
sever
diseas
destroy
key
mediat
ga
exchang
allow
viral
exposur
endotheli
cell
earli
interact
influenza
viru
alveolar
macrophag
resid
lung
airway
epitheli
line
import
determin
alveolar
diseas
progress
fragil
layer
breach
cytokin
viral
antigen
exposur
endotheli
layer
amplifi
inflamm
endotheli
cell
major
sourc
proinflammatori
cytokin
drive
magnitud
charact
subsequ
innat
adapt
immun
respons
ultim
involv
signific
portion
airway
infecti
respons
either
direct
viral
infect
damag
respond
immun
system
repres
physiolog
failur
inabl
lung
perform
primari
function
ga
exchang
result
multipl
nonexclus
mechan
includ
obstruct
airway
loss
alveolar
structur
loss
lung
epitheli
integr
direct
epitheli
cell
kill
degrad
critic
extracellular
matrix
maintain
structur
lung
latter
area
rel
understudi
relationship
immun
respons
extracellular
matrix
structur
fulli
elucid
key
pathway
regul
extracellular
matrix
degrad
regener
context
infect
restor
healthi
lung
function
fulli
understood
therapi
target
pathway
may
efficaci
later
respons
tradit
antivir
found
reduc
effect
toward
end
report
found
inhibit
collagenas
limit
tissu
damag
improv
surviv
mous
model
sever
influenza
viru
infect
model
influenzapneumococc
coinfect
target
downstream
effect
inflamm
immuneassoci
lung
damag
may
viabl
mean
limit
influenzaassoci
patholog
approach
address
host
respons
directli
rather
sole
focus
viru
includ
target
innat
immun
pathway
amplifi
inflammatori
signal
contribut
epitheli
damag
inflammasom
innat
signal
complex
requir
secret
implic
multipl
studi
influenzaassoci
patholog
suppress
inflammasom
activ
later
infect
target
key
compon
inflammasom
signal
downstream
influenza
posit
effect
recoveri
anim
model
follow
inflammasom
activ
secondari
cytokin
chemokin
signal
lead
recruit
tissuedamag
neutrophil
inflammatori
monocyt
popul
experi
block
signal
key
receptor
pathway
necessari
neutrophil
recruit
site
inflamm
show
protect
murin
infect
influenza
staphylococcu
pneumonia
combin
infect
given
promin
secondari
bacteri
infect
discuss
detail
influenzaassoci
diseas
hostdirect
therapi
may
signific
clinic
util
neutrophil
mediat
tissu
damag
secret
high
level
tissu
remodel
enzym
mmp
also
amplifi
inflamm
secret
extracellular
trap
net
mous
model
net
highli
correl
acut
lung
injuri
could
exacerb
shift
cellular
infiltr
favor
neutrophil
deplet
macrophag
similar
net
structur
observ
human
suffer
sever
influenza
diseas
one
studi
sever
viru
infect
level
net
admiss
correl
clinic
score
apach
ii
tabl
host
viral
mechan
influenzaassoci
pathogenesi
target
host
inflamm
increas
interest
develop
new
therapeut
sever
influenza
one
studi
use
wellcharacter
mtor
inhibitor
rapamycinsirolimu
suppress
inflamm
lead
improv
outcom
correl
reduc
inflammasom
activ
target
mtor
pathway
mean
reduc
inflamm
promot
recoveri
implic
host
metabol
etiolog
sever
influenza
diseas
given
central
role
mtor
play
nutrient
sens
metabol
disrupt
note
local
system
analys
sever
case
influenza
metabol
intervent
shown
alter
host
respons
profil
way
could
protect
harm
depend
infect
context
exampl
mous
model
bacteri
sepsi
influenza
viru
infect
glucos
restrict
oppos
effect
protect
bacteri
sepsi
exacerb
influenzaassoci
diseas
role
metabol
modul
viral
infect
complex
host
need
particular
nutrient
support
immun
activ
viru
requir
signific
host
cell
metabol
resourc
maintain
replic
includ
glucos
glutamin
target
viral
metabol
requir
may
open
addit
therapeut
window
addit
global
metabol
state
within
host
shown
profound
effect
cours
viral
infect
progress
ardsphenotyp
obes
anim
human
significantli
suscept
sever
influenza
increas
lung
injuri
sustain
viral
replic
indic
failur
host
immun
potenti
increas
viral
pathogenesi
mechan
relat
obes
suscept
like
complex
multifactori
includ
increas
inflamm
decreas
wound
heal
obes
individu
addit
obes
dampen
featur
adapt
immun
may
delay
viral
clearanc
increas
suscept
initi
infect
approxim
hospit
patient
laboratoryconfirm
influenza
diagnos
acut
pneumonia
patient
develop
pneumonia
like
young
year
old
old
year
old
caucasian
nurs
home
resid
chronic
lung
heart
diseas
histori
smoke
commonli
immunocompromis
note
pregnant
women
extrem
obes
nativ
american
alaska
nativ
also
prone
develop
sever
influenza
complic
nonetheless
unlik
season
epidem
influenza
viru
infect
display
classic
risk
factor
pandem
associ
higher
rate
hospit
respiratori
failur
previous
healthi
young
adult
recent
larg
cohort
australia
new
zealand
report
winter
predomin
viru
strain
associ
unpreced
high
level
icu
admiss
due
viral
bacteri
pneumonia
even
higher
pandem
reliabl
statist
actual
incid
preval
influenzarel
ard
either
pediatr
adult
popul
howev
known
vast
major
ard
caus
bacteri
sepsi
noninfecti
etiolog
trauma
pancreat
smoke
inhal
drug
toxic
observ
studi
suggest
within
small
proport
viralinduc
ard
pediatr
popul
caus
respiratori
syncyti
viru
influenza
influenza
predomin
viral
etiolog
ard
adult
popul
european
cohort
eurosurveil
show
risk
factor
independ
associ
ard
patient
diagnos
influenza
age
year
old
pregnanc
obes
protect
factor
associ
ard
femal
sex
influenza
vaccin
infect
influenza
influenza
b
virus
notabl
factor
remain
significantli
associ
death
increas
sever
score
age
greater
year
old
anoth
cohort
china
appear
viral
strain
signific
factor
compar
ard
caus
associ
higher
diseas
sever
higher
rate
mechan
complic
hospitalacquir
pneumonia
increas
mortal
potenti
new
risk
factor
develop
ard
influenza
season
perform
cardiac
surgeri
challeng
diagnos
pneumonia
ard
patient
posit
laboratori
result
influenza
relat
tempor
clinic
event
influenza
viru
infect
alon
caus
sever
pneumonia
ard
also
act
conjunct
bacteri
infect
discuss
preced
pneumonia
episod
caus
secondari
bacteri
infect
commonli
aureu
pneumonia
follow
episod
nosocomi
pneumonia
clinician
commonli
fail
clinic
diagnos
influenza
twothird
patient
confirm
influenza
viru
infect
case
sever
pneumonia
ard
reliabl
clue
influenza
possibl
causal
agent
present
peak
season
epidem
symptomatolog
alon
distinguish
sever
influenza
viral
bacteri
respiratori
infect
primari
influenza
pneumonia
show
persist
andor
subsequ
worsen
respiratori
symptom
secondari
bacteri
pneumonia
occur
week
relaps
initi
influenza
symptom
end
subsid
howev
bacteri
coinfect
also
occur
day
influenza
ill
onset
said
sever
pneumonia
admit
icu
viral
etiolog
immun
respons
influenza
share
mani
common
pathway
respons
bacteria
thu
surpris
influenza
viru
infect
similar
clinic
present
bacteri
sepsi
specif
sever
studi
demonstr
tolllik
receptor
main
receptor
gramposit
gramneg
bacteria
also
relat
influenza
pathogen
inflammatori
respons
also
vari
accord
viral
strain
exampl
viru
produc
stronger
respons
viru
blood
macrophag
produc
robust
cytokin
product
strain
addit
similar
bacteri
sepsi
endotheli
damag
microvascular
permeabl
chang
lead
tissu
edema
organ
failur
observ
influenza
viru
infect
analog
influenza
viru
predisposit
secondari
bacteri
pneumonia
influenza
viru
increas
progress
secondari
bacteri
sepsi
adult
sever
influenzainduc
organ
failur
pediatr
patient
high
pim
score
acut
renal
failur
greater
risk
mortal
larg
multin
cohort
evalu
caus
sepsi
approxim
patient
southeast
asia
found
sepsi
caus
influenza
virus
recent
winter
season
predomin
viru
strain
australasian
studi
report
icu
admiss
sepsi
much
higher
expect
author
attribut
part
influenza
viru
season
occurr
viralbacteri
respiratori
coinfect
describ
centuri
includ
period
influenza
pandem
howev
year
ago
gener
evid
point
uncommon
event
without
major
chang
patient
outcom
recent
advent
rapid
avail
microbiolog
diagnost
test
eg
realtim
reversetranscriptas
polymeras
chain
reaction
reveal
differ
pictur
nowaday
viral
etiolog
per
se
respons
onethird
case
communityacquir
pneumonia
cap
etiolog
includ
influenza
parainfluenza
coronaviru
rhinoviru
metapneumoviru
adenoviru
respiratori
syncyti
viru
less
frequent
microorgan
viral
infect
present
concurr
bacteri
cap
known
occur
frequenc
adult
pediatr
popul
interestingli
would
intuit
assum
cap
would
sever
manifest
coinfect
recent
sever
studi
demonstr
viralbacteri
infect
also
affect
patient
hospitalacquir
pneumonia
hap
larg
cohort
studi
patient
hospit
sever
influenza
follow
risk
factor
identifi
develop
hap
need
mechan
ventil
sepsi
icu
admiss
first
day
lymphocytopenia
older
age
anemia
note
grow
evid
suggest
pediatr
adult
patient
present
suspect
bacteri
sepsi
may
viral
coinfect
eg
influenza
metapneumoviru
coronaviru
respiratori
syncyti
viru
two
third
case
commonli
miss
clinician
current
data
still
lack
proof
clinic
present
viralbacteri
coinfect
directli
lead
wors
outcom
grow
bodi
evid
suggest
influenzabacteri
coinfect
associ
higher
morbid
higher
mortal
fact
recent
studi
show
presenc
coinfect
adult
influenzaassoci
acut
respiratori
syndrom
requir
extracorpor
membran
oxygen
significantli
associ
fourfold
increas
mortal
anoth
studi
children
staphylococcu
aureu
coinfect
influenzarel
critic
ill
also
show
ninefold
signific
increas
mortal
mechan
increas
suscept
bacteri
coinfect
influenza
viru
infect
focu
mani
studi
lung
immun
environ
substanti
alter
influenza
viru
infect
earli
deplet
alveolar
macrophag
cell
play
key
role
respons
mani
bacteri
infect
loss
may
play
critic
part
increas
suscept
addit
normal
regulatori
mechan
induc
inflammatori
respons
trigger
viral
infect
includ
upregul
key
neg
regul
surfac
lung
immun
cell
includ
airway
macrophag
suppressor
activ
necessari
allow
tissu
repair
avoid
patholog
consequ
overzeal
immun
respons
allow
window
opportun
bacteria
similarli
influenza
viru
infect
induc
system
glucocorticoid
dampen
inflamm
protect
tissu
integr
allow
increas
bacteri
growth
shown
mous
model
influenza
viruslisteria
coinfect
block
glucocorticoid
respons
actual
led
death
inflamm
associ
influenza
viru
infect
demonstr
balanc
toler
pathogen
resist
difficult
determin
coinfect
host
acut
myositi
accompani
rhabdomyolysi
may
rare
happen
commonli
children
present
extrem
tender
lower
extrem
laboratori
investig
show
mark
elev
serum
creatinin
phosphokinas
myoglobinuria
myocard
pericard
also
rare
describ
clinic
case
demonstr
autopsi
studi
central
nervou
system
complic
associ
influenza
includ
enceph
acut
dissemin
encephalomyel
transvers
myeliti
asept
mening
guillainbarr
syndrom
tabl
influenza
viru
affect
respiratori
tract
direct
viral
infect
damag
immun
system
respons
human
respiratori
epithelium
site
hemagglutinin
ha
molecul
effect
cleav
gener
infecti
viru
particl
viru
transmiss
occur
contact
aerosol
respiratori
fomit
infect
individu
inabl
lung
perform
primari
function
ga
exchang
result
multipl
mechan
includ
obstruct
airway
loss
alveolar
structur
loss
lung
epitheli
integr
direct
epitheli
cell
kill
degrad
critic
extracellular
matrix
approxim
hospit
patient
laboratoryconfirm
influenza
diagnos
acut
pneumonia
patient
develop
pneumonia
like
year
old
year
old
caucasian
nurs
home
resid
chronic
lung
heart
diseas
histori
smoke
immunocompromis
influenza
primarili
caus
sever
pneumonia
also
present
conjunct
follow
secondari
bacteri
infect
commonli
aureu
pneumonia
influenza
associ
higher
predisposit
bacteri
sepsi
ard
viral
infect
present
concurr
bacteri
pneumonia
known
occur
frequenc
adult
pediatr
popul
influenza
viru
associ
unpreced
high
level
intens
care
unit
icu
admiss
influenza
viru
predomin
viral
etiolog
acut
respiratori
distress
syndrom
ard
adult
risk
factor
independ
associ
ard
age
year
old
pregnanc
obes
protect
factor
femal
sex
influenza
vaccin
infect
influenza
influenza
b
virus
icu
particularli
winter
season
influenza
suspect
patient
typic
symptom
epidemiolog
also
patient
sever
pneumonia
ard
sepsi
without
bacteri
coinfect
well
patient
enceph
myocard
rhabdomyolysi
